Bachem - Process Development and Manufacturing of Peptides and Complex Organic Molecules as APIs

Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry. Bachem is specialised in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes.

With headquarters in Bubendorf, Switzerland, and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides.

Peptidic active pharmaceutical ingredients (APIs)

Bachem is the leading independent supplier of peptidic active pharmaceutical ingredients (APIs) for the human and veterinary pharmaceutical market. With our high capacity and the outstanding quality of our products Bachem holds a unique position.

• Almost 40 years of outstanding expertise
• Fully independent company
• More than 70 generic APIs
• Large batch sizes for LHRH analogs
• Best value in our class
• Quality you can trust
• Full range of technical and regulatory support
• Superior customer service
• Prompt quotation and delivery

Solid-phase peptide synthesis

Bachem offers more than 50 peptidic generic APIs. They are produced in annual quantities of up to hundreds of kilograms. We have great expertise in large-scale solid-phase peptide synthesis (Boc- and Fmoc-strategies) and solution-phase peptide synthesis. Purification procedures include large-scale preparative high performance liquid chromatography (preparative HPLC), conventional chromatography (ion exchange, gel chromatography) and counter-current (Craig) distribution.

Custom synthesis of cytostatic peptides and cytostatic small organic molecules

Our three GMP compliant manufacturing facilities for APIs located in Switzerland and the US fulfill the highest standards and are regularly inspected by the FDA and local authorities. Recently, Bachem set up a new production unit for the custom synthesis of cytostatic peptides as well as cytostatic small organic molecules.

GMP Production

Bachem's manufacturing facilities comply with the latest GMP standards of regulatory agencies such as Food and Drug Administration (FDA), Swissmedic (Switzerland) and the Regierungspräsidium Tübingen (Germany).

Bachem has experience with the production of pharmaceutical grade peptides and specialty chemicals under cGMP conditions. We maintain close working relationships with our customers through all stages of product development, from initial small-scale trial batches through scale-up to full commercial production.

cGMP facilities are located at:

• Bubendorf, Switzerland
• Vionnaz, Switzerland
• Torrance, California, USA

Production and release of finished dosage forms (Clinalfa® brand) under the responsibility of Bachem at:

• Weil am Rhein, Germany

www.bachem.com

Europe/Asia:

Bachem AG
Hauptstrasse 144
4416 Bubendorf - Switzerland
Tel +41 61 935 2323
Fax +41 61 935 2325
sales.ch@bachem.com

US:

Bachem Americas, Inc.
3132 Kashiwa Street
Torrance, CA 90505 - USA
Tel +1 888 422 2436
+1 888 4BACHEM
+1 310 539 4171
Fax +1 310 539 9428
sales.us@bachem.com